Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.

doi:10.1097/IGC.0000000000001161

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Feb 2018

Choi Min Chul, Jang Ja-Hyun, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Lee Je Ho

Abstract excerpt

OBJECTIVE: The aim of the present study was to investigate unclassified variants (UVs) in BRCA1 and 2 of Korean patients with ovarian cancer. METHODS: We retrospectively analyzed 138 patients diagnosed with ovarian/fallopian tubal/peritoneal cancer between January 2013 and January 2016, whose BRCA genetic test results and clinical characteristics were available for review. Patient peripheral blood lymphocyte...

Topics

Adult
Aged
Aged, 80 and over
BRCA1 Protein
BRCA2 Protein
DNA Mutational Analysis
Female
Genetic Predisposition to Disease
Genetic Testing
Humans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Middle Aged

Mutation

Ovarian Neoplasms

Polymorphism, Single Nucleotide

Republic of Korea

Retrospective Studies

Young Adult

Source

Open in PubMed

Identifiers

PMID: 29240602
DOI: 10.1097/IGC.0000000000001161

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.PMID 29240602Read ↗

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.Semantic proximity Read ↗

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients.Semantic proximity Read ↗

Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.Semantic proximity Read ↗

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.Semantic proximity Read ↗

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.Semantic proximity Read ↗

Analysis of BRCA1/2 variants of unknown significance in patients with breast cancer from a prospective KOHBRA studySemantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patientsSemantic proximity Read ↗

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.Semantic proximity Read ↗

BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.Semantic proximity Read ↗

The role of BRCA1/2 in hereditary and familial breast and ovarian cancersSemantic proximity Read ↗

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.